Publications
5674 Results
- Journal / Conference
- British Journal of Urology International, Mar;117(3):500-506
- Year
- 2016
- Research Committee(s)
- Cancer Control
- PMID
- PMID26269564
- PMC
- PMC4826049
- Study Number(s)
- SWOG-9217
Non-steroidal anti-inflammatory drug use not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Blood Cancer Journal 2016 Mar 25;6:e410. doi: 10.1038/bcj.2016.19
- Year
- 2016
- Research Committee(s)
- Myeloma
- PMID
- PMID27015287
- PMC
- PMC4817101
- Study Number(s)
- S0120
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention Mar;25(3):463-469
- Year
- 2016
- Research Committee(s)
- Cancer Control
- PMID
- PMID26715424
- PMC
- PMC4779655
- Study Number(s)
- SWOG-9217
Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention Jul;25(7):1050-1058
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27197287
- PMC
- PMC5086806
- Study Number(s)
- S0000
Selenium- or vitamin E-related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT
- Journal / Conference
- Cancer Aug 1;122(15):2332-2340; 2016 May 10 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Cancer Control
- PMID
- PMID27164191
- PMC
- PMC4956504
- Study Number(s)
- SWOG-9217
Association of androgen metabolism gene polymorphisms with steroid hormone concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- American Journal of Clinical Oncology 2016 Sep 15 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Brain
- PMID
- PMID27635620
- PMC
- PMC5352534
- Study Number(s)
- E4397
Preradiation chemotherapy for adult high-risk medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)
- Journal / Conference
- Journal of Clinical Oncology, Sep 1;34(25):2997-3004; 2016 Jul 5 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27382104
- PMC
- PMC5012710
- Study Number(s)
- SWOG-8736 (INT-0093)
Continued risk of relapse independent of treatment modality in limited stage diffuse large B-cell lymphoma: Final and long-term analysis of SWOG Study S8736
- Journal / Conference
- JAMA Oncology Jul 1;2(7):875-881; 2016 Mar 10 Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID26967260
- PMC
- PMC4945370
The scientific impact of positive and negative phase III cancer clinical trials
- Journal / Conference
- Journal of Clinical Oncology 34:(suppl 4S; abstr 192); poster GI Cancers Symposium (1/21/16 - 1/23/2016, San Francisco, CA)
- Year
- 2016
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80802
Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)- CALGB 80802
- Journal / Conference
- International Journal of Cancer May 15;138(10):2368-2382
- Year
- 2016
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID26685908
- PMC
- PMC4837898
- Study Number(s)
- SWOG-9217